Synergistic effect of clinically available β lactamases inhibitors on cefiderocol activity against carbapenemase producing Gram negative organisms

Affiliations

G. Bianco: Microbiology and Virology Unit , University Hospital Città della Salute e della Scienza di Torino, Turin; Department of Public Health and Paediatrics , University of Turin
S. Comini: Microbiology and Virology Unit , University Hospital Città della Salute e della Scienza di Torino, Turin; Department of Public Health and Paediatrics , University of Turin
P. Gaibani: Operative Unit of Microbiology , IRCCS Azienda Ospedaliero Universitaria di Bologna
M. Boattini: Microbiology and Virology Unit , University Hospital Città della Salute e della Scienza di Torino, Turin; Department of Public Health and Paediatrics , University of Turin
G. Banche: Department of Public Health and Paediatrics , University of Turin
C. Costa: Microbiology and Virology Unit , University Hospital Città della Salute e della Scienza di Torino, Turin; Department of Public Health and Paediatrics , University of Turin
P. Nordmann: Medical and Molecular Microbiology , Faculty of Science and Medicine, University of Fribourg, Fribourg; National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg , Fribourg
R. Cavallo: Microbiology and Virology Unit , University Hospital Città della Salute e della Scienza di Torino, Turin; Department of Public Health and Paediatrics , University of Turin

Abstract

Not available.